CBD Anti-inflammatory Benefits: For Copeland Biosciences, That's The Rub

Toronto firm is making CBD topicals physicians use with patients and it's s ready to market products OTC as soon as it has Canada's stamp of approval. It's waiting for US regulatory landscape to settle before crossing the border. Company also has research help from Marc Feldmann, immunologist whose work led to most-used therapy for rheumatoid arthritis, other autoimmune diseases.

Canada_Map

More from Regulation

More from Policy & Regulation